Central serous chorioretinopathy (CSC) commonly affects middle-aged males and is characterized by blurred or dim vision due to fluid accumulation beneath the retina. While the pathogenesis is unknown, it is thought to involve abnormalities in the choroid leading to increased permeability. Treatment options include laser photocoagulation or photodynamic therapy (PDT) to reduce choroidal congestion and leakage. The effectiveness of PDT varies depending on findings from indocyanine green angiography, with more intense choroidal hyperfluorescence on ICG correlating to better treatment outcomes and resolution of subretinal fluid.